Research Progress of Glycolytic Reprogramming in Oral Squamous Cell Carcinoma

Ting LI; Wei-Hua GUO

doi:10.12259/j.issn.2095-610X.S20230611

Volume 44 Issue 6

Jun. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2023 > 44(6): 155-161

Ting LI, Wei-Hua GUO. Research Progress of Glycolytic Reprogramming in Oral Squamous Cell Carcinoma[J]. Journal of Kunming Medical University, 2023, 44(6): 155-161. doi: 10.12259/j.issn.2095-610X.S20230611

Citation:

Ting LI, Wei-Hua GUO. Research Progress of Glycolytic Reprogramming in Oral Squamous Cell Carcinoma[J]. Journal of Kunming Medical University, 2023, 44(6): 155-161. doi: 10.12259/j.issn.2095-610X.S20230611

Citation:

PDF( 556 KB)

Research Progress of Glycolytic Reprogramming in Oral Squamous Cell Carcinoma

doi: 10.12259/j.issn.2095-610X.S20230611

Ting LI^{1, 2, 3, 4, 5},
Wei-Hua GUO^{1, 2, 3, 4, 5, 6
,
,}

1.
National Laboratory for Oral Regenerative Medicine Engineering，West China Hospital of Stomatology，Sichuan University
2.
Engineering Research Center of Oral Translational Medicine，West China Hospital of Stomatology，Sichuan University
3.
National Key Laboratory of Oral Diseases，West China Hospital of Stomatology
4.
National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology，Sichuan University，Chengdu
5.
Department of Pediatric Dentistry，West China School of Stomatology，Chengdu Sichuan 610041
6.
Yunnan Key Laboratory of Stomatology，The Affiliated Hospital of Stomatology，School of Stomatology，Kunming Medical University，Kunming Yunnan 650500，China

Received Date: 2023-03-09
Publish Date: 2023-06-25

Abstract

Abstract

Oral squamous cell carcinoma （OSCC） is the most common malignant tumor in the oral and maxillofacial region with high incidence and poor prognosis. Cancer cells change their metabolism through glycolytic metabolic reprogramming to support their increased demand for ATP. Glycolytic reprogramming mediates the development of multisystem tumors, including oral squamous cell carcinoma, involving multiple signaling pathways and key factors. In this paper, the changes of glycolytic metabolism, key factors and potential clinical diagnostic and theraputic approches of OSCC are summarized, and the role of OSCC in oral squamous cell carcinoma is reviewed in order to provide new research directions and ideas.
- Glycolysis metabolism,
- Oral squamous cell carcinoma,
- Cell proliferation,
- Molecular targeted therapy

FullText(HTML)

References(53)

References

[1]	Chi A C,Day T A,Neville B W. Oral cavity and oropharyngeal squamous cell carcinoma-an update[J]. CA:A Cancer Journal for Clinicians,2015,65(5):401-421. doi: 10.3322/caac.21293
[2]	Romero-Garcia S,Lopez-Gonzalez J S,Báez-Viveros J L,et al. Tumor cell metabolism: an integral view[J]. Cancer Biol Ther,2011,12(11):939-948. doi: 10.4161/cbt.12.11.18140
[3]	Warburg O,Posener K,Negelein E. On the metabolism of carcinoma cells[J]. Biochemische Zeitschrift,1924,152:309-344.
[4]	Wang Y,Xia Y,Lu Z. Metabolic features of cancer cells[J]. Cancer Communications (London,England),2018,38(1):65. doi: 10.1186/s40880-018-0335-7
[5]	Ghanavat M,Shahrouzian M,Deris Zayeri Z,et al. Digging deeper through glucose metabolism and its regulators in cancer and metastasis[J]. Life Sci,2021,264:118603. doi: 10.1016/j.lfs.2020.118603
[6]	Somashekar B S,Kamarajan P,Danciu T,et al. Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues[J]. Journal of Proteome Research,2011,10(11):5232-5241. doi: 10.1021/pr200800w
[7]	Boffetta P,Hashibe M. Alcohol and cancer[J]. The Lancet Oncology,2006,7(2):149-156. doi: 10.1016/S1470-2045(06)70577-0
[8]	Nguyen A, Kim A H, Kang M K, et al. Chronic alcohol exposure promotes cancer stemness and glycolysis in oral/oropharyngeal squamous cell carcinoma cell lines by activating NFAT signaling [J]. International Journal of Molecular Sciences, 2022, 23（17）: 9779.
[9]	Zhou X,Xue D,Qiu J. Identification of biomarkers related to glycolysis with weighted gene co-expression network analysis in oral squamous cell carcinoma[J]. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck,2022,44(1):89-103.
[10]	Robey R B,Hay N. Is AKT the “Warburg kinase”?-AKT-energy metabolism interactions and oncogenesis[J]. Seminars in cancer biology,2009,19(1):25-31. doi: 10.1016/j.semcancer.2008.11.010
[11]	Marquard F, Jücker M J B P. PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer [J]. 2020, 172: 113729.
[12]	Raggi C,Taddei M L,Rae C,et al. Metabolic reprogramming in cholangiocarcinoma[J]. J Hepatol,2022,77(3):849-864. doi: 10.1016/j.jhep.2022.04.038
[13]	Tang Y C,Hsiao J R,Jiang S S,et al. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation[J]. Theranostics,2021,11(11):5232-5247. doi: 10.7150/thno.53417
[14]	Wang L W,Yu Y,Chen J,et al. Protein kinase D1 regulates the growth and metabolism of oral squamous carcinoma cells in tumor microenvironment[J]. West China Journal of Stomatology,2019,37(6):577-582.
[15]	Chen J,Cui B,Fan Y,et al. Protein kinase D1 regulates hypoxic metabolism through HIF-1 and glycolytic enzymes incancer cells[J]. Oncology Reports,2018,40(2):1073-1082.
[16]	Fu L,Pelicano H,Liu J,et al. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo[J]. Cell,2002,111(1):41-50. doi: 10.1016/S0092-8674(02)00961-3
[17]	Zheng B,Larkin D W,Albrecht U,et al. The mPer2 gene encodes a functional component of the mammalian circadian clock[J]. Nature,1999,400(6740):169-173. doi: 10.1038/22118
[18]	Long W, Gong X, Yang Y, et al. Downregulation of PER2 promotes tumor progression by enhancing glycolysis via the phosphatidylinositol 3-kinase/Protein kinase B pathway in oral squamous cell carcinoma [J]. Journal of Oral and Maxillofacial Surgery, 2020, 78（10）: 10.
[19]	Zheng M,Cao M X,Yu X H,et al. STAT3 promotes invasion and aerobic glycolysis of human oral squamous cell carcinoma via inhibiting foxO1[J]. Front Oncol,2019,9:1175. doi: 10.3389/fonc.2019.01175
[20]	Grimm M, Cetindis M, Lehmann M, et al. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? [J]. Journal of Translational Medicine, 2014, 12: 208.
[21]	Brizel D M,Schroeder T,Scher R L,et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer[J]. International Journal of Radiation Oncology Biology Physics,2001,51(2):349-353. doi: 10.1016/S0360-3016(01)01630-3
[22]	Wang Y,Zhang X,Zhang Y,et al. Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma[J]. Cancer Biology & Therapy,2015,16(6):839-845.
[23]	Yang W,Xia Y,Hawke D,et al. PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis[J]. Cell,2014,158(5):1210.
[24]	Kurihara-shimomura M, Sasahira T, Nakashima C, et al. The multifarious functions of pyruvate kinase M2 in oral cancer cells [J]. International Journal of Molecular Sciences, 2018, 19（10）: 2907.
[25]	Cai H, Li J, Zhang Y, et al. LDHA promotes oral squamous cell carcinoma progression through facilitating glycolysis and epithelial-mesenchymal transition[J]. Frontiers in Oncology, 2019, 9: 1446.
[26]	Yuan C,Li Z,Wang Y,et al. Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer[J]. Histopathology,2014,65(5):595-605. doi: 10.1111/his.12441
[27]	Wigfield S M,Winter S C,Giatromanolaki A,et al. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer[J]. British Journal of Cancer,2008,98(12):1975-1984. doi: 10.1038/sj.bjc.6604356
[28]	Pai S, Yadav V K, Kuo K T, et al. PDK1 inhibitor BX795 improves cisplatin and radio-efficacy in oral squamous cell carcinoma by downregulating the PDK1/CD47/Akt-mediated glycolysis signaling pathway[J]. International Journal of Molecular Sciences, 2021, 22（21）: 11492.
[29]	Guo D,Tong Y,Jiang X,et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα[J]. Cell Metabolism,2022,34(9):1312-24.e6. doi: 10.1016/j.cmet.2022.08.002
[30]	Patra K C,Wang Q,Bhaskar P T,et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer[J]. Cancer Cell,2013,24(2):213-228. doi: 10.1016/j.ccr.2013.06.014
[31]	Christison T, Wang J, Huang Y, et al. Profiling anionic polar metabolites in oral cancer using capillary ion chromatography and high resolution accurate mass spectrometry [J]. Abstracts of Papers of the American Chemical Society, 2015, 249: 49.
[32]	Wang L, Wang J, Shen Y, et al. Fructose-1, 6-bisphosphatase 2 inhibits oral squamous cell carcinoma tumorigenesis and glucose metabolism via downregulation of c-myc[J]. Oxidative Medicine and Cellular Longevity, 2022, 2022.
[33]	Simoes-sousa S,Granja S,Pinheiro C,et al. Prognostic significance of monocarboxylate transporter expression in oral cavity tumors[J]. Cell Cycle,2016,15(14):1865-1873. doi: 10.1080/15384101.2016.1188239
[34]	Nakazato K,Mogushi K,Kayamori K,et al. Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas[J]. Oncology Letters,2019,18(2):1372-1380.
[35]	Gholami S,Chamorro-petronacci C,Pérez-sayáns M,et al. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study[J]. Journal of Applied Oral Science:Revista FOB,2023,31:e20220461. doi: 10.1590/1678-7757-2022-0461
[36]	Chang Y C, Chi L H, Chang W M, et al. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis [J]. Journal of Hematology & Oncology, 2017, 10（1）: 11.
[37]	Zhang Y,Cai H,Liao Y,et al. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell-like properties and the epithelial-mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway[J]. International Journal of Oncology,2020,57(3):743-755. doi: 10.3892/ijo.2020.5083
[38]	Nakashima C,Yamamoto K,Fujiwara-tani R,et al. Expression of cytosolic malic enzyme (ME1) is associated with disease progression in human oral squamous cell carcinoma[J]. Cancer Science,2018,109(6):2036-2045. doi: 10.1111/cas.13594
[39]	Li Y J,Huang T H,Hsiao M,et al. Suppression of fructose-bisphosphate aldolase C expression as a predictor of advanced oral squamous cell carcinoma[J]. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck,2016,38:E1075-E85.
[40]	Wilde L,Roche M,Domingo-vidal M,et al. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development[J]. Seminars in Oncology,2017,44(3):198-203. doi: 10.1053/j.seminoncol.2017.10.004
[41]	Muhammad S N H, Safuwan N A M, Yaacob N S, et al. Regulatory mechanism on anti-Glycolytic and anti-metastatic activities induced by strobilanthes crispus in breast cancer, in vitro [J]. Pharmaceuticals （Basel, Switzerland）, 2023, 16（2）: 153.
[42]	Bai R, Meng Y, Cui J. Therapeutic strategies targeting metabolic characteristics of cancer cells [J]. Critical Reviews in Oncology/Hematology, 2023, 104037.
[43]	Samuel S M,Varghese E,Satheesh N J,et al. Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy[J]. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie,2023,164:114911.
[44]	Huang G, Chen S, Washio J, et al. Glycolysis-related gene analyses indicate that DEPDC1 promotes the malignant progression of oral squamous cell carcinoma via the WNT/β-catenin signaling pathway[J]. International Journal of Molecular Sciences, 2023, 24（3）: 1992.
[45]	Liu X, Zhao T, Yuan Z, et Al. MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44 [J]. Cell Death Discovery, 2022, 8（1）: 216.
[46]	Li M, Gao F, Zhao Q, et al. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing AKT-c-MYC signaling-mediated aerobic glycolysis [J]. Cell Death & Disease, 2020, 11（5）: 381.
[47]	Wei J, Wu J, Xu W, et al. Salvanic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1 alpha signaling pathway [J]. Cell Death & Disease, 2018, 9: 599.
[48]	Wei J,Xie G,Ge S,et al. Metabolic transformation of DMBA-induced carcinogenesis and inhibitory effect of salvianolic acid B and breviscapine treatment[J]. Journal of Proteome Research,2012,11(2):1302-1316. doi: 10.1021/pr2009725
[49]	Lee N, Jang W J, Seo J H, et al. 2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met [J]. Metabolites, 2019, 9（9）: 3515-3524.
[50]	Lin C X,Tu C W,Ma Y K,et al. Nobiletin inhibits cell growth through restraining aerobic glycolysis via PKA-CREB pathway in oral squamous cell carcinoma[J]. Food Science & Nutrition,2020,8(7):3515-3524.
[51]	Zhang G,Fu J,Su Y,et al. Opposite effects of garcinol on tumor energy metabolism in oral squamous cell carcinoma cells[J]. Nutrition and Cancer-an International Journal,2019,71(8):1403-1411. doi: 10.1080/01635581.2019.1607409
[52]	Sur S, Nakanishi H, Flaveny C, et al. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract [J]. Cell Communication and Signaling, 2019, 17（1）: 131.
[53]	Kawata M,Ogi K,Nishiyama K,et al. Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma[J]. Journal of Oral Pathology & Medicine,2017,46(10):979-985.

Relative Articles(20)

Relative Articles

[1]	Yongjun DENG, Qian CHEN, Jianbin ZOU, Zheng GONG, Huanpeng LIU. Overexpression of ZIC1 Gene Inhibits Proliferation of Pleural Mesothelioma Cells by Activating P53 Signaling Pathway. Journal of Kunming Medical University, 2024, 45(4): 35-40. doi: 10.12259/j.issn.2095-610X.S20240405
[2]	Xiaobing GUO, Xiaowen LI, Hengxi LI, Yan CAO, Ping LI. miR-212-3p Targeted Regulation of NAP1L1 Inhibits Glioma Cell Proliferation，Migration and EMT. Journal of Kunming Medical University, 2024, 45(11): 22-30. doi: 10.12259/j.issn.2095-610X.S20241104
[3]	Chenxi LI, Zhuocen ZHA, Na LI, Lin LUO, Yang YANG, Wenlin CHEN. Selection of Intensive Adjuvant Therapy for Triple-positive Breast Cancer. Journal of Kunming Medical University, 2023, 44(10): 180-188. doi: 10.12259/j.issn.2095-610X.S20231020
[4]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[5]	Hui WANG, Wenjun ZENG, Haiping ZHANG, Ruiwei GUO. Effects of Store-operated Calcium Channel Molecule Orai3 on Rat Coronary Artery Smooth Muscle Cells Proliferation. Journal of Kunming Medical University, 2023, 44(4): 16-22. doi: 10.12259/j.issn.2095-610X.S20230423
[6]	Caihong LIANG, Mingyao MENG, Xinxin LI, Jingjing XIONG, Meng LI, Mei LIU, Zongliu HOU, Yongkun HUANG. Effect of Intestinal Flora Metabolites Deoxycholic Acid on the Proliferation and Cell Cycle of Human Umbilical Cord Mesenchymal Stem Cells. Journal of Kunming Medical University, 2023, 44(4): 23-30. doi: 10.12259/j.issn.2095-610X.S20230402
[7]	Shiyuan YANG, Hao ZHANG, Tuqiang HU. Effect of Pristimerin on Proliferation of Oral Squamous Cell Carcinoma CAL-27 by Regulating Autophagy. Journal of Kunming Medical University, 2023, 44(10): 92-99. doi: 10.12259/j.issn.2095-610X.S20231024
[8]	Xiaohan WANG, Shanmao MOU, Cuifang HAO, Linlin REN, Min WANG, Tong ZHAO. Platelet-rich Plasma Promotes the Proliferation of Human Endometrial Mesenchymal Stem Cells (EnMSCs) through the PI3K/AKT/mTOR Signaling Pathway. Journal of Kunming Medical University, 2022, 43(1): 26-32. doi: 10.12259/j.issn.2095-610X.S20220126
[9]	Wei YUAN, Mingyao MENG, Xinxin LI, Jingjing XIONG, Meng LI, Jia CAO, Mei LIU, Zongliu HOU, Yongkun HUANG. Effects of Dose-response and Time-dependent of Endotoxin on Proliferation of Human Umbilical Cord Mesenchymal Stem Cells. Journal of Kunming Medical University, 2022, 43(9): 7-12. doi: 10.12259/j.issn.2095-610X.S20220928
[10]	Shibing QIAN, Mingyao MENG, Hongbin YU, Kaiwen DUAN, Changquan LI, Zhigang XIA. Effect of Panax Noto-ginseng Saponins on the Proliferation of Human Stem Cells from Apical Papilla. Journal of Kunming Medical University, 2022, 43(10): 22-27. doi: 10.12259/j.issn.2095-610X.S20221018
[11]	Yu-hang QUAN, Zhong-hui WANG, Shan-shan LI, Guang-shun LIU. Sevoflurane Inhibits Xuanwei Lung Cancer Cell Line XWLC-05. Journal of Kunming Medical University, 2021, 42(12): 1-5. doi: 10.12259/j.issn.2095-610X.S20211202
[12]	Shun-hui YIN, Jian-zhong ZHOU, Zi-liang LI. Tiger17 Promotes the Proliferation and Migration of Human Oral Mucosa Fibroblast Cells. Journal of Kunming Medical University, 2021, 42(8): 128-131. doi: 10.12259/j.issn.2095-610X.S20210823
[13]	Tang Wei Wei , He Yong Wen . . Journal of Kunming Medical University, 2018, 39(10): 42-45.
[14]	Hu Zheng Xiong . Effect of TGF-β2 and geneX on the Proliferation and Osteogenic Differentiation of BrdU-labeled Bone Mesenchymal Stem Cells. Journal of Kunming Medical University,
[15]	Yuan Yong . . Journal of Kunming Medical University,
[16]	Zhang Jian . . Journal of Kunming Medical University,
[17]	Chen Xian Yu . . Journal of Kunming Medical University,
[18]	Zhao Yu Min . . Journal of Kunming Medical University,
[19]	Xu Ke Dong . . Journal of Kunming Medical University,
[20]	. TRB3 Mediates Homocysteine-induced Inhibition of Endothelial Cells Proliferation. Journal of Kunming Medical University,